Chaser proven effective in clinical trials

In IRB-approved, randomized, double-blinded, placebo-controlled crossover clinical trials, Chaser was proven effective at helping to prevent 17 common hangover symptoms including headache, nausea and fatigue.

According to the trial's executive summary, "The efficacy of the product 'Chaser' appears to be proven based on the clinical trial. All of the major symptoms associated with moderate alcohol consumption were improved while on the product." The report goes on to say, "There appears to be no drawbacks to this product with respect to safety as determined by this trial. Furthermore, the active ingredients have a long medical history of use and are generally recognized as safe (GRAS) by the FDA."